Chimeric Therapeutics Ltd

CHM

ASX

Chimeric Therapeutics Limited (CHM) stands as a clinical-stage cell therapy company at the forefront of Australia's advancements in cell therapy. Dedicated to realising the potential of cell therapy for a broader spectrum of cancer patients, Chimeric is led by a team of pioneers and experts in the field. Their focus spans from initial discovery through to the development and eventual commercialisation of innovative cell therapies. Presently, Chimeric boasts a diverse portfolio encompassing two autologous CAR T cell therapies alongside allogeneic NK cell therapies, promising new avenues in the fight against cancer.

Latest Posts

Line Chart with Gradient

Leave a Comment on CHM


Comments for CHM

    Latest Posts

    Social Media Auto Publish Powered By : XYZScripts.com

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions